2012 ©
             Publication
Journal Publication
Research Title A peptide chimera comprised of the bovine lactoferrin antimicrobial peptides lactoferricin and lactoferrampin exhibits potent killing activity against Burkholderia pseudomallei 
Date of Distribution 25 October 2012 
Conference
     Title of the Conference 5th Annual Symposium on Host Defence Peptides 
     Organiser The Division of Molecular Host Defence of Utrecht University and the section of Oral Biochemistry of the Academic Centre for Dentistry Amsterdam 
     Conference Place Utrecht University 
     Province/State Utrech, The Netherlands 
     Conference Date 25 October 2012 
     To 25 October 2012 
Proceeding Paper
     Volume
     Issue
     Page
     Editors/edition/publisher  
     Abstract Burkholderia pseudomallei is the etiological agent of melioidosis, which is a life-threatening infectious disease in Southeast Asia and Northern Australia. Successful treatment of melioidosis patients is difficult because the pathogen is inherently resistant to most commonly used antibiotics, including β-lactams, aminoglycosides, macrolides and polymyxins. The current treatment requires an initial intensive therapy with Ceftazidime (CAZ) administered parenterally for up to 4 weeks followed with an eradication therapy for up to 6 month with a cocktail of antibiotics administered orally. Lactoferricin and lactoferrampin are two antimicrobial stretches of the innate immunity factor bovine lactoferrin, which have been led to the development a series of antimicrobial peptides with broad spectrum activity against a range of Gram-positive and Gram-negative bacteria. In this study we evaluated the antimicrobial activity of heterodimers of peptides from both stretches, against B. pseudomallei in comparison to CAZ, using 7 strains of this bacterium including a CAZ-resistant strain. As the major route of infection is the respiratory tract the cytotoxicity of the peptides was examined using the lung epithelium cell line A549. The antimicrobial potency of the individual peptides was dose dependent and differed between the bacterial isolates. In all cases the heterodimer LFchimera displayed higher killing activity than their constituent peptides. Time-kill experiments showed LFchimera at a concentration as low as 5 μM can kill B. pseudomallei within 2 h. Also B. pseudomallei 979b, shown to be resistant to CAZ, was highly susceptible to LFchimera, though a higher concentration was needed (10 μM). At these concentrations of LFchimera we found no reduction of viability of the A549 cells. These data indicate that LFchimera might be potential as alternative therapeutic agents against B. pseudomallei. 
Author
517070003-7 Mr. AEKKALAK PUKNUN [Main Author]
Medicine Doctoral Degree

Peer Review Status ไม่มีผู้ประเมินอิสระ 
Level of Conference นานาชาติ 
Type of Proceeding Abstract 
Type of Presentation Oral 
Part of thesis true 
Presentation awarding false 
Attach file
Citation 0